Investment analysts at HC Wainwright cut their FY2026 earnings per share (EPS) estimates for Ekso Bionics in a research note ...

Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $-0.07. Operator: Greetings. And welcome to ...

Ekso Bionics Holdings Inc (EKSO) reports a 5% revenue increase and strategic alliances to enhance market access, despite challenges in reimbursement processes.

Shares of EKSO stock opened at $0.35 on Tuesday. The stock has a market cap of $8.69 million, a price-to-earnings ratio of -0.54 and a beta of 1.43. The stock has a 50-day moving average of $0.60 ...

Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology ...

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology ...

Reports Q4 revenue $5.09M, consensus $5.05M. “We are pleased to close out 2024 with record fourth quarter revenue, improved gross margin and ...

Ekso Bionics Holdings Inc. (Nasdaq: EKSO), a San Rafael-based creator of robotic exoskeletal devices, announced last week $5.1 million in revenue for the fourth quarter. That’s a 5% increase ...

Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $3.4 million in its fourth quarter. On a per-share basis, the San ...

As of December 31, 2024, the Company had cash and restricted cash of $6.5 million. Ekso Bionics is pleased to invite all interested parties to participate in a conference call today at 1:30 p.m ...

Greetings, and welcome to the Ekso Bionics Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will ...